They responded to me twice in July:
July 30:
Thanks for the follow-up email.
One of the methods available to public companies (BioAdaptives, Inc. is a public Delaware corporation traded in the OTC marketplace under the symbol "BDPT") for the purpose of raising funds is through an exempt SEC Regulation A Offering Circular, as filed and approved by the SEC. Such Offering Circulars are on file in the public domain and can be reviewed by any interested investor. BDPT filed such a document during the Spring of 2022, and, once accepted, was available to all interested parties. A total of 200M common shares was submitted for a best-efforts sale at a fixed price of $0.001 USD per share. Interested investors could contact the Company and request a Subscription Agreement in order to make an offer for shares to be purchased under the Offering Circular. We have been operating against the current Offering Circular and submitted Subscription Agreements. Said Reg A offering is open until the maximum offered shares are subscribed or the Company closes the offer.
Hopefully events will provide a basis for enhancing our trading prices such that dilution is offset. We thank you for your support.
Sincerely,
Robert Ellis, President
BioAdaptives, Inc.
Las Vegas, Nevada USA
rwe@bioadaptives.com
Response July 19th:
Thank you for your recent comments concerning BioAdaptives (BDPT) and our recent activities. We appreciate your interest, your investment, and your input. Whether from a shareholder, potential investor, creditor, or an interested outside party, we welcome all inputs concerning our company.
Due to the sizable and diverse shareholder base, and the legal requirement to keep everyone equally informed or current information equally available through public channels, we use a variety of methods designed to identify and share the latest most current Company information / data to as broad an audience as possible. First, we rely upon the periodic Forms reporting to the SEC as necessary to keep current with their requirements for all public companies. Our 10-Q & 10-K submittals offer timely quarterly updates (a new 10-Q for the second quarter will be filed, and available for online review within the next 3 weeks), and, in addition, 8-K reports are used to announce interim material events as they are concluded. Other SEC filings are prepared and posted as situations and events demand. All SEC filings are immediately and completely available online to the general public. Also, we use periodic press releases to report key events via postings on a variety of media outlets. Finally, our primary website, info@bioadaptives.com, as well as product-specific sites, are kept current with news, products, and key company activities.
With the above tools we attempt to provide the necessary vehicles to provide an opportunity for everyone to stay equally and fairly informed regarding events and activities. Our objective is to provide a level playing field for all interested parties to make necessary decisions concerning BioAdaptives.
Thanks again for your interest and inquiry. I hope this helps in understanding our process.
Bob Ellis, President & Director
BioAdaptives, Inc.
Las Vegas, Nevada USA
rwe@bioadaptives.com
They may not like that I've posted their replies on this board but I'm doing it for two reasons under the assumption whatever they reply with is in strict coherence to SEC rules which, as we read through these emails, is apparent as they are in compliance and do not divulge information which hasn't already been shared in the PR or filings: 1) To prove to people on this board that it's been 3 months since I've heard back from Robert Ellis, & 2) We have made contact before and here's the proof this thing might not be a scam.
My hope, yes hope isn't much to rely on, is the company is working diligently to move the dial for all stakeholders.
One reason they might not respond to our emails is they don't want to jeopardize anything from private communications to public forums. I get it but it sucks for us investors as we wait and hope they are working for us and can't divulge info legally or ethically.
Let's give them a week to respond as Robert Ellis usually answers emails on the weekends & I will confirm either way here with the board next week sometime. $BDPT let's say a prayer and send our emails letting them know we need information/communications.
